Cargando…
Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors
SIMPLE SUMMARY: The clinical consequences of irradiating the cardiac substructures during stereotactic body radiation therapy (SBRT) remains unclear. We evaluated 83 lung cancer patients who underwent SBRT for early stage lung cancer. Using specialized software, we generated structures for fourteen...
Autores principales: | Farrugia, Mark, Yu, Han, Ma, Sung Jun, Iovoli, Austin J., Pokharel, Saraswati, Sharma, Umesh C., Fung-Kee-Fung, Simon, Malik, Nadia, Singh, Anurag K., Malhotra, Harish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945864/ https://www.ncbi.nlm.nih.gov/pubmed/35326542 http://dx.doi.org/10.3390/cancers14061391 |
Ejemplares similares
-
Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome
por: Farrugia, Mark, et al.
Publicado: (2021) -
Comparison of Survival Outcomes of Single- and Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC
por: Huang, Karen, et al.
Publicado: (2023) -
Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
por: Huang, Karen, et al.
Publicado: (2023) -
Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
por: Iovoli, Austin J., et al.
Publicado: (2022) -
Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)